Heterocyclic thiazole derivatives of formula (I) that modulate the activity of stearoyl-CoA desaturase (SCD) enzymes are disclosed, wherein the variables are as defined in the specification. These compounds are suitable for treating diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, dermatological disorders and the like.